Works by Tonn, Joerg C.

Results: 37

18 F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors.

Published in:

Cancers, 2021, v. 13, n. 13, p. 3163, doi. 10.3390/cancers13133163

By:

Mittlmeier, Lena M.;
Suchorska, Bogdana;
Ruf, Viktoria;
Holzgreve, Adrien;
Brendel, Matthias;
Herms, Jochen;
Bartenstein, Peter;
Tonn, Joerg C.;
Unterrainer, Marcus;
Albert, Nathalie L.

Publication type:

Article

Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma.

Published in:

Acta Neuropathologica, 2024, v. 147, n. 1, p. 1, doi. 10.1007/s00401-023-02662-1

By:

Weller, Michael;
Felsberg, Jörg;
Hentschel, Bettina;
Gramatzki, Dorothee;
Kubon, Nadezhda;
Wolter, Marietta;
Reusche, Matthias;
Roth, Patrick;
Krex, Dietmar;
Herrlinger, Ulrich;
Westphal, Manfred;
Tonn, Joerg C.;
Regli, Luca;
Maurage, Claude-Alain;
von Deimling, Andreas;
Pietsch, Torsten;
Le Rhun, Emilie;
Reifenberger, Guido

Publication type:

Article

Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape.

Published in:

Neuro-Oncology, 2024, v. 26, p. S208, doi. 10.1093/neuonc/noae125

By:

Weller, Michael;
Albert, Nathalie L;
Galldiks, Norbert;
Bink, Andrea;
Preusser, Matthias;
Sulman, Erik P;
Treyer, Valerie;
Wen, Patrick Y;
Tonn, Joerg C;
Rhun, Emilie Le

Publication type:

Article

The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1805, doi. 10.1093/neuonc/noae107

By:

Bent, Martin J van den;
French, Pim J;
Brat, Daniel;
Tonn, Joerg C;
Touat, Mehdi;
Ellingson, Benjamin M;
Young, Robert J;
Pallud, Johan;
Deimling, Andreas von;
Sahm, Felix;
Branger, Dominique Figarella;
Huang, Raymond Y;
Weller, Michael;
Mellinghoff, Ingo K;
Cloughsey, Tim F;
Huse, Jason T;
Aldape, Kenneth;
Reifenberger, Guido;
Youssef, Gilbert;
Karschnia, Philipp

Publication type:

Article

Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.

Published in:

Neuro-Oncology, 2024, v. 26, n. 10, p. 1742, doi. 10.1093/neuonc/noae082

By:

Wang, Justin Z;
Landry, Alexander P;
Raleigh, David R;
Sahm, Felix;
Walsh, Kyle M;
Goldbrunner, Roland;
Yefet, Leeor S;
Tonn, Jörg C;
Gui, Chloe;
Ostrom, Quinn T;
Barnholtz-Sloan, Jill;
Perry, Arie;
Ellenbogen, Yosef;
Hanemann, C Oliver;
Jungwirth, Gerhard;
Jenkinson, Michael D;
Tabatabai, Ghazaleh;
Mathiesen, Tiit I;
McDermott, Michael W;
Tatagiba, Marcos

Publication type:

Article

Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.

Published in:

International Journal of Cancer, 2001, v. 93, n. 3, p. 445, doi. 10.1002/ijc.1342

By:

Koch, Arend;
Waha, Anke;
Tonn, Jörg C.;
Sörensen, Nils;
Berthold, Frank;
Wolter, Marietta;
Reifenberger, Julia;
Hartmann, Wolfgang;
Friedl, Waltraut;
Reifenberger, Guido;
Wiestler, Otmar D.;
Pietsch, Torsten

Publication type:

Article

Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC.

Published in:

International Journal of Cancer, 2000, v. 87, n. 2, p. 261, doi. 10.1002/1097-0215(20000715)87:2<261::AID-IJC18>3.0.CO;2-6

By:

Vajkoczy, Peter;
Menger, Michael D.;
Goldbrunner, Roland;
Ge, Shugang;
Fong, T. Annie T.;
Vollmar, Brigitte;
Schilling, Lothar;
Ullrich, Axel;
Hirth, K. Peter;
Tonn, Jörg C.;
Schmiedek, Peter;
Rempel, Sandra A.

Publication type:

Article

Investigational PET tracers in neuro-oncology—What's on the horizon? A report of the PET/RANO group.

Published in:

Neuro-Oncology, 2022, v. 24, n. 11, p. 1815, doi. 10.1093/neuonc/noac131

By:

Galldiks, Norbert;
Langen, Karl-Josef;
Albert, Nathalie L;
Law, Ian;
Kim, Michelle M;
Villanueva-Meyer, Javier E;
Soffietti, Riccardo;
Wen, Patrick Y;
Weller, Michael;
Tonn, Joerg C

Publication type:

Article

Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patients.

Published in:

Neuro-Oncology, 2020, v. 22, n. 9, p. 1388, doi. 10.1093/neuonc/noaa044

By:

Stoecklein, Veit M;
Stoecklein, Sophia;
Galiè, Franziska;
Ren, Jianxun;
Schmutzer, Michael;
Unterrainer, Marcus;
Albert, Nathalie L;
Kreth, Friedrich-W;
Thon, Niklas;
Liebig, Thomas;
Ertl-Wagner, Birgit;
Tonn, Joerg-C;
Liu, Hesheng

Publication type:

Article

Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression.

Published in:

Neuro-Oncology, 2020, v. 22, n. 1, p. 17, doi. 10.1093/neuonc/noz147

By:

Galldiks, Norbert;
Kocher, Martin;
Ceccon, Garry;
Werner, Jan-Michael;
Brunn, Anna;
Deckert, Martina;
Pope, Whitney B;
Soffietti, Riccardo;
Rhun, Emilie Le;
Weller, Michael;
Tonn, Jörg C;
Fink, Gereon R;
Langen, Karl-Josef

Publication type:

Article

Comment on "Hypometabolic gliomas on FET-PET—is there an inverted U-curve for survival?".

Published in:

Neuro-Oncology, 2019, v. 21, n. 12, p. 1612, doi. 10.1093/neuonc/noz173

By:

Galldiks, Norbert;
Verger, Antoine;
Zaragori, Timothée;
Unterrainer, Marcus;
Suchorska, Bogdana;
Lohmann, Philipp;
Tonn, Jörg C;
Langen, Karl-Josef;
Albert, Nathalie L

Publication type:

Article

Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.

Published in:

Neuro-Oncology, 2019, v. 21, n. 10, p. 1331, doi. 10.1093/neuonc/noz083

By:

Galldiks, Norbert;
Unterrainer, Marcus;
Judov, Natalie;
Stoffels, Gabriele;
Rapp, Marion;
Lohmann, Philipp;
Vettermann, Franziska;
Dunkl, Veronika;
Suchorska, Bogdana;
Tonn, Jörg C;
Kreth, Friedrich-Wilhem;
Fink, Gereon R;
Bartenstein, Peter;
Langen, Karl-Josef;
Albert, Nathalie L

Publication type:

Article

PET imaging in patients with brain metastasis—report of the RANO/PET group.

Published in:

Neuro-Oncology, 2019, v. 21, n. 5, p. 585, doi. 10.1093/neuonc/noz003

By:

Galldiks, Norbert;
Langen, Karl-Josef;
Albert, Nathalie L;
Chamberlain, Marc;
Soffietti, Riccardo;
Kim, Michelle M;
Law, Ian;
Rhun, Emilie Le;
Chang, Susan;
Schwarting, Julian;
Combs, Stephanie E;
Preusser, Matthias;
Forsyth, Peter;
Pope, Whitney;
Weller, Michael;
Tonn, Jörg C

Publication type:

Article

Imaging and diagnostic advances for intracranial meningiomas.

Published in:

Neuro-Oncology, 2019, v. 21, p. i44, doi. 10.1093/neuonc/noy143

By:

Huang, Raymond Y;
Bi, Wenya Linda;
Griffith, Brent;
Kaufmann, Timothy J;
Fougère, Christian la;
Schmidt, Nils Ole;
Tonn, Jöerg C;
Vogelbaum, Michael A;
Wen, Patrick Y;
Aldape, Kenneth;
Nassiri, Farshad;
Zadeh, Gelareh;
Dunn, Ian F;
Meningiomas, International Consortium on

Publication type:

Article

Advances in multidisciplinary therapy for meningiomas.

Published in:

Neuro-Oncology, 2019, v. 21, p. i18, doi. 10.1093/neuonc/noy136

By:

Brastianos, Priscilla K;
Galanis, Evanthia;
Butowski, Nicholas;
Chan, Jason W;
Dunn, Ian F;
Goldbrunner, Roland;
Herold-Mende, Christel;
Ippen, Franziska M;
Mawrin, Christian;
McDermott, Michael W;
Sloan, Andrew;
Snyder, James;
Tabatabai, Ghazaleh;
Tatagiba, Marcos;
Tonn, Joerg C;
Wen, Patrick Y;
Aldape, Kenneth;
Nassiri, Farshad;
Zadeh, Gelareh;
Jenkinson, Michael D

Publication type:

Article

PET imaging in patients with meningioma--report of the RANO/PET Group.

Published in:

Neuro-Oncology, 2017, v. 19, n. 12, p. 1576, doi. 10.1093/neuonc/nox112

By:

Galldiks, Norbert;
Albert, Nathalie L.;
Sommerauer, Michael;
Grosu, Anca L.;
Ganswindt, Ute;
Law, Ian;
Preusser, Matthias;
Le Rhun, Emilie;
Vogelbaum, Michael A.;
Zadeh, Gelareh;
Dhermain, Frédéric;
Weller, Michael;
Langen, Karl-Josef;
Tonn, Jörg C.

Publication type:

Article

Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).

Published in:

Neuro-Oncology, 2017, v. 19, n. 2, p. 162, doi. 10.1093/neuonc/now241

By:

Soffietti, Riccardo;
Abacioglu, Ufuk;
Baumert, Brigitta;
Combs, Stephanie E.;
Kinhult, Sara;
Kros, Johan M.;
Marosi, Christine;
Metellus, Philippe;
Radbruch, Alexander;
Villa Freixa, Salvador S.;
Brada, Michael;
Carapella, Carmine M.;
Preusser, Matthias;
Le Rhun, Emilie;
Rudà, Roberta;
Tonn, Joerg C.;
Weber, Damien C.;
Weller, Michael

Publication type:

Article

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Published in:

Neuro-Oncology, 2016, v. 18, n. 9, p. 1199, doi. 10.1093/neuonc/now058

By:

Albert, Nathalie L.;
Weller, Michael;
Suchorska, Bogdana;
Galldiks, Norbert;
Soffietti, Riccardo;
Kim, Michelle M.;
la Fougère, Christian;
Pope, Whitney;
Law, Ian;
Arbizu, Javier;
Chamberlain, Marc C.;
Vogelbaum, Michael;
Ellingson, Ben M.;
Tonn, Joerg C.

Publication type:

Article

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma--results from the DIRECTOR trial.

Published in:

Neuro-Oncology, 2016, v. 18, n. 4, p. 549, doi. 10.1093/neuonc/nov326

By:

Suchorska, Bogdana;
Weller, Michael;
Tabatabai, Ghazaleh;
Senft, Christian;
Hau, Peter;
Sabel, Michael C.;
Herrlinger, Ulrich;
Ketter, Ralf;
Schlegel, Uwe;
Marosi, Christine;
Reifenberger, Guido;
Wick, Wolfgang;
Tonn, Jörg C.;
Wirsching, Hans-Georg

Publication type:

Article

Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.

Published in:

Neuro-Oncology, 2012, v. 14, n. suppl_4, p. iv100, doi. 10.1093/neuonc/nos206

By:

Weller, Michael;
Stupp, Roger;
Hegi, Monika E.;
van den Bent, Martin;
Tonn, Joerg C.;
Sanson, Marc;
Wick, Wolfgang;
Reifenberger, Guido

Publication type:

Article

Functional Outcome and Clinical Significance of Long-term Intrathecal Baclofen Therapy for Severe Spasticity.

Published in:

Neurorehabilitation & Neural Repair, 1996, v. 10, n. 3, p. 159, doi. 10.1177/154596839601000303

By:

Ochs, Günter A.;
Tonn, Jörg C.

Publication type:

Article

Improved Detection of Transosseous Meningiomas Using 68Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRI.

Published in:

Journal of Nuclear Medicine, 2017, v. 58, n. 10, p. 1580, doi. 10.2967/jnumed.117.191932

By:

Kunz, Wolfgang G.;
Jungblut, Lisa M.;
Kazmierczak, Philipp M.;
Vettermann, Franziska J.;
Bollenbacher, Andreas;
Tonn, Jörg C.;
Schichor, Christian;
Rominger, Axel;
Albert, Nathalie L.;
Bartenstein, Peter;
Reiser, Maximilian F.;
Cyran, Clemens C.

Publication type:

Article

Analysis of 18F-FET PET for Grading of Recurrent Gliomas: Is Evaluation of Uptake Kinetics Superior to Standard Methods?

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 3, p. 393

By:

Pöpperl, Gabriele;
Kreth, Friedrich W.;
Herms, Jochen;
Koch, Walter;
Mehrkens, Jan H.;
Gildehaus, Franz J.;
Kretzschmar, Hans A.;
Tonn, Jörg C.;
Tatsch, Klaus

Publication type:

Article

Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.

Published in:

Journal of Neuro-Oncology, 2019, v. 145, n. 3, p. 469, doi. 10.1007/s11060-019-03312-x

By:

Biczok, Annamaria;
Jungk, Christine;
Egensperger, Rupert;
von Deimling, Andreas;
Suchorska, Bogdana;
Tonn, Joerg C.;
Herold-Mende, Christel;
Schichor, Christian

Publication type:

Article

TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.

Published in:

Journal of Neuro-Oncology, 2018, v. 139, n. 3, p. 671, doi. 10.1007/s11060-018-2912-7

By:

Biczok, Annamaria;
Kraus, Theo;
Suchorska, Bogdana;
Terpolilli, Nicole A.;
Thorsteinsdottir, Jun;
Giese, Armin;
Tonn, Joerg C.;
Schichor, Christian

Publication type:

Article

Loss of heterozygosity on chromosome 22 in human ependymomas.

Published in:

Acta Neuropathologica, 2002, v. 103, n. 4, p. 415, doi. 10.1007/s00401-001-0479-3

By:

Huang, Bei;
Starostik, Petr;
Kühl, Joachim;
Tonn, Jörg C.;
Roggendorf, Wolfgang

Publication type:

Article

Analysis of the TSC2 gene in human medulloblastoma.

Published in:

Acta Neuropathologica, 2001, v. 102, n. 4, p. 380, doi. 10.1007/s004010100393

By:

Przkora, Rene;
Meyer-Puttlitz, Birgit;
Schmitt, Ottmar;
Berthold, Frank;
Nöthen, Markus;
Krauss, J.;
Tonn, Jörg C.;
von Deimling, Andreas;
Wiestler, Otmar D.;
Pietsch, Torsten

Publication type:

Article

Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.

Published in:

Acta Neuropathologica, 2001, v. 102, n. 1, p. 69, doi. 10.1007/s004010000353

By:

Kraus, Jürgen A.;
de Millas, Walter;
Sörensen, Nils;
Herbold, Christian;
Schichor, Christian;
Tonn, Jörg C.;
Wiestler, Otmar D.;
von Deimling, Andreas;
Pietsch, Torsten

Publication type:

Article

Molecular genetic alterations in pleomorphic xanthoastrocytoma.

Published in:

Acta Neuropathologica, 1996, v. 91, n. 3, p. 293, doi. 10.1007/s004010050428

By:

Paulus, Werner;
Lisle, David K.;
Tonn, Jörg C.;
Wolf, Helmut K.;
Roggendorf, Wolfgang;
Reeves, Steven A.;
Louis, David N.

Publication type:

Article

Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?

Published in:

Neuro-Oncology Practice, 2025, v. 12, n. 2, p. 291, doi. 10.1093/nop/npaf006

By:

Geurts, Marjolein;
Berchtold, Luzia;
Koenig, Franz;
Nabors, Burt;
Reardon, David A;
Tonn, Joerg C;
Stupp, Roger;
Gorlia, Thierry;
Weller, Michael;
Preusser, Matthias;
Group, EORTC Brain Tumor

Publication type:

Article

TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic 18F-FET PET?

Published in:

Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.645316

By:

Unterrrainer, Marcus;
Ruf, Viktoria;
von Rohr, Katharina;
Suchorska, Bogdana;
Mittlmeier, Lena Maria;
Beyer, Leonie;
Brendel, Matthias;
Wenter, Vera;
Kunz, Wolfgang G.;
Bartenstein, Peter;
Herms, Jochen;
Niyazi, Maximilian;
Tonn, Jörg C.;
Albert, Nathalie Lisa

Publication type:

Article

Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy.

Published in:

International Journal of Cancer, 2014, v. 134, n. 10, p. 2437, doi. 10.1002/ijc.28576

By:

Weller, Michael;
Kaulich, Kerstin;
Hentschel, Bettina;
Felsberg, Joerg;
Gramatzki, Dorothee;
Pietsch, Torsten;
Simon, Matthias;
Westphal, Manfred;
Schackert, Gabriele;
Tonn, Joerg C.;
Deimling, Andreas;
Davis, Thomas;
Weiss, William Andrew;
Loeffler, Markus;
Reifenberger, Guido

Publication type:

Article

2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size.

Published in:

International Journal of Cancer, 2012, v. 131, n. 3, p. 766, doi. 10.1002/ijc.26425

By:

Capper, David;
Simon, Matthias;
Langhans, Claus-Dieter;
Okun, Jürgen G.;
Tonn, Jörg C.;
Weller, Michael;
Deimling, Andreas von;
Hartmann, Christian

Publication type:

Article

Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.

Published in:

International Journal of Cancer, 2011, v. 129, n. 3, p. 659, doi. 10.1002/ijc.26083

By:

Felsberg, Jörg;
Thon, Niklas;
Eigenbrod, Sabina;
Hentschel, Bettina;
Sabel, Michael C.;
Westphal, Manfred;
Schackert, Gabriele;
Kreth, Friedrich Wilhelm;
Pietsch, Torsten;
Löffler, Markus;
Weller, Michael;
Reifenberger, Guido;
Tonn, Jörg C.

Publication type:

Article

O6-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation.

Published in:

PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0017156

By:

Kreth, Simone;
Thon, Niklas;
Eigenbrod, Sabina;
Lutz, Juergen;
Ledderose, Carola;
Egensperger, Rupert;
Tonn, Joerg C.;
Kretzschmar, Hans A.;
Hinske, Ludwig C.;
Kreth, Friedrich W.

Publication type:

Article

FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 12, p. 1933, doi. 10.1007/s00259-007-0534-y

By:

Pöpperl, Gabriele;
Kreth, Friedrich W.;
Mehrkens, Jan H.;
Herms, Jochen;
Seelos, Klaus;
Koch, Walter;
Gildehaus, Franz J.;
Kretzschmar, Hans A.;
Tonn, Jörg C.;
Tatsch, Klaus

Publication type:

Article

Serial O-(2-[18F]fluoroethyl)- L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 7, p. 792, doi. 10.1007/s00259-005-0053-7

By:

Pöpperl, Gabriele;
Götz, Claudia;
Rachinger, Walter;
Schnell, Oliver;
Gildehaus, Franz;
Tonn, Joerg C.;
Tatsch, Klaus

Publication type:

Article

Works by Tonn, Joerg C.

18 F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors.

Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma.

Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape.

The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.

Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.

Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC.

Investigational PET tracers in neuro-oncology—What's on the horizon? A report of the PET/RANO group.

Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patients.

Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression.

Comment on "Hypometabolic gliomas on FET-PET—is there an inverted U-curve for survival?".

Photopenic defects on O-(2-[<sup>18</sup>F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.

PET imaging in patients with brain metastasis—report of the RANO/PET group.

Imaging and diagnostic advances for intracranial meningiomas.

Advances in multidisciplinary therapy for meningiomas.

PET imaging in patients with meningioma--report of the RANO/PET Group.

Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma--results from the DIRECTOR trial.

Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.

Functional Outcome and Clinical Significance of Long-term Intrathecal Baclofen Therapy for Severe Spasticity.

Improved Detection of Transosseous Meningiomas Using <sup>68</sup>Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRI.

Analysis of <sup>18</sup>F-FET PET for Grading of Recurrent Gliomas: Is Evaluation of Uptake Kinetics Superior to Standard Methods?

Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.

TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.

Loss of heterozygosity on chromosome 22 in human ependymomas.

Analysis of the TSC2 gene in human medulloblastoma.

Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.

Molecular genetic alterations in pleomorphic xanthoastrocytoma.

Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?

TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic <sup>18</sup>F-FET PET?

Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy.

2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size.

Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.

O<sup>6</sup>-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation.

FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

Serial O-(2-[<sup>18</sup>F]fluoroethyl)- L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma.